The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

Explore the potential of Celldex's Barzolvolimab in Phase 3 for CSU, with strong efficacy but safety concerns, promising ...

Some of these airborne particles, such as pollen, pet dander and mold spores, are irritants that can aggravate people's allergies. These particles can make their way into our bodies as we breathe ...

Users who’ve signed up can post up to 60 seconds of video, according to details shared by developer Daniel Supernault on Mastodon. He added that using sounds and remixing others’ videos is ...

Following a year and a half of use, my Apple Pencil had to be retired – the tip cracked off while the stylus was snug in my backpack during a flight. Thank you, #thoughtsandprayers, but life ...

BRUSSELS, Oct 25 (Reuters) - The European Union and China have agreed to hold further technical negotiations soon on possible alternatives to tariffs on China-built electric vehicles, the European ...

Useful items to barter and trade for survival in case of societal collapse. Here is a list of 90+ items you can start ...

Medically reviewed by Jurairat J. Molina, MD Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria ...